Answers are grounded in this paper and cite their sources.
Cohort study characterizes treatment experiences of patients with seropositive generalized myasthenia gravis using biologic therapy, suggesting valuable insights for future management.
To characterize the indications and experiences of patients with seropositive generalized myasthenia gravis (gMG) treated with biologic therapy.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: